शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
STARHEALTHNSESTAR HEALTH & AL INS CO L· InsuranceHighNeutral
Announced Wed, 29 Jul, 2026 · 18:02 IST

Star Health Q1 FY27: PAT Rs 438 cr, revenue up 13% YoY

Results restatedEBITDA margin expansionResults View source PDFExplain this filing

STARHEALTH · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+1.0%Reaction day
₹601.45
prior close
₹615.35
announcement price
After-mkt
timing
Nifty Smallcap 250market-0.7%+1.7% vs market
General Insurance peers, median of 5sector+0.1%+0.9% vs sector

On the reaction day the stock moved 1.7 pts more than Nifty Smallcap 250 and 0.9 pts more than its General Insurance peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-1.9
10m
-1.3
15m
-2.0
30m
-2.1
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+1.0-0.7+1.7+0.1+0.9
Next day
-0.7-0.3-0.4+0.3-1.0
2d
-1.8+1.0-2.9+1.6-3.4
3d
-2.0+1.2-3.2+1.2-3.2
4d
-2.1+1.9-4.0+1.4-3.5
5d
-4.8+2.1-6.9+1.0-5.8
1w
-4.7+2.0-6.8+0.0-4.7
15d
-4.5+2.0-6.5+0.2-4.7
1m
-6.0+2.2-8.2-1.2-4.9
2m
-11.2-1.0-10.2-3.6-7.7
3m
-11.7pendingpending-4.1-7.6
UpDownMarket · Nifty Smallcap 250Sector · General Insurance peers, median of 5Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Star Health declared Q1 FY27 standalone results on July 29, 2026. Insurance revenue rose to Rs 4,917 cr from Rs 4,336 cr YoY, up 13.4%. PAT stood at Rs 438 cr. Combined ratio improved to 90.93% from 91.75% YoY. Claims ratio improved to 67.48% from 68.20%. Return on equity turned positive at 5.57% versus negative 0.61% YoY. First results reported under new Ind AS 117 and 109 framework. Joint auditors MSKA and T R Chadha gave a clean limited review.

Likely market impact

Improved claims and combined ratios signal better underwriting. Ind AS transition and clean audit review are positive signals for the stock.